Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbits

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2700-2705

  Groll, Andreas H ^a   Sein, Tin ^a   Petraitis, Vidas ^a   Petraitiene, Ruta ^a   Callender, Diana ^a   Gonzalez, Corina E ^a   Giri, Neelam ^a   Bacher, John ^b   Piscitelli, Stephen ^c   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BMS 181184; PRADIMICIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0031685551     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2700     Document Type: Article

References (24)

1. Beck-Sague, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1913. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
2. Bristol-Myers Squibb. 1995. BMS 181184 investigator brochure, version 1. Bristol-Myers Squibb, Princeton, N.J.
3. Bristol-Myers Squibb. Unpublished data.
4. Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
5. D'Argenio, D. Z., and A. Schumitzky. 1990. Adapt II user's guide. Biomedical Simulations Resource, University of Southern California, Los Angeles.
6. Drusano, G. L., W. Liu, R. Perkins, A. Madu, C. Madu, M. Mayers, and M. H. Miller. 1995. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrob. Agents Chemother. 39:1683-1687.
7. Fung-Tomc, J. C., B. Minassian, E. Huczko, B. Kolek, D. P. Bonner, and R. E. Kessler. 1995. In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrob. Agents Chemother. 39:295-300.
8. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed., p. 455-459. Marcel Dekker, Inc., New York, N.Y.
9. Gonzalez, C. E., D. Shetty, N. Giri, W. Love, K. Klygis, C. Lyman, J. Bacher, and T. J. Walsh. 1996. Efficacy of pradimicin against disseminated candidiasis, abstr. F181, p. 131. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Gonzalez, C. E., D. Shetty, N. Giri, W. Love, K. Klygis, T. Sein, C. Lyman, J. Bacher, and T. J. Walsh. 1996. Efficacy of pradimicin against invasive pulmonary aspergillosis, abstr. F182, p. 131. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Graybill, J. R. 1996. The future of antifungal therapy. Clin. Infect. Dis. 22(Suppl. 2):S166-S178.
12. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23-32.
13. Hiemenz, J. W., and T. J. Walsh. 1996. Lipid formulations of amphotericin B: recent progress and future directions. Clin. Infect. Dis. 22(Suppl. 2):S133-S144.
14. Kakushima, M., S. Masuyoshi, M. Hirano, M. Shinoda, A. Ohta, H. Kamei, and T. Oki. 1991. In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative. Antimicrob. Agents Chemother. 35:2185-2190.
15. Kauffman, C. A. 1996. Role of azoles in antifungal therapy. Clin. Infect. Dis. 22(Suppl. 2):S148-S153.
16. Oki, T., M. Konishi, K. Tomatsu, K. Tomita, K. Saitoh, M. Tsunakawa, M. Nishio, T. Myaki, and H. Kawaguchi. 1988. Pradimicin, a novel class of potent antifungal antibiotics. J. Antibiot. 41:1701-1704.
17. Oki, T., O. Tenmyo, M. Hirano, K. Tomatsu, and H. Kamei. 1990. Pradimicins A, B and C: new antifungal antibiotics. II. In vitro and in vivo biological activities. J. Antibiot. 43:763-770.
18. Oki, T., M. Kakushima, M. Hirano, A. Takahashi, A. Ohta, S. Masuyoshi, M. Hatori, and H. Kamei. 1992. In vitro and in vivo antifungal activities of BMS-181184. J. Antibiot. 45:1512-1517.
19. Patterson, T. F., W. R. Kirkpatrick, and R. K. McAtee. 1996. The activity of pradimicin (BMS-181184) in experimental invasive aspergillosis, abstr. B51, p. 31. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Restrepo, M., L. Najvar, R. Bocanegra, M. Luther, and J. Graybill. 1996. Comparison of the efficacy of BMS-181184 (BMS) and amphotericin B (AMB) against hematogenous Candida tropicalis (CT) infection in immuno-suppressed mice, abstr. F183, p. 131. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
21. Sawada, Y., K. Numata, T. Murakami, H. Tanimichi, S. Yamamoto, and T. Oki. 1990. Calcium-dependent anticandidal action of pradimicin A. J. Antibiot. 43:715-721.
22. Walsh, T. J., P. Bacher, and P. A. Pizzo. 1988. Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits. Lab. Anim. Med. 38:467-470.
23. Walsh, T. J., J. W. Hiemenz, and E. Anaissie. 1996. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect. Dis. Clin. North Am. 10:365-400.
24. Yamaoka, K., T. Nakagawa, and T. Uno. 1978. Application of Akaike's information criterion in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6:165-175.